The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Image in cardiology

Percutaneous closure of left atrial appendage after transcatheter aortic valve implantation - an interventional approach to avoid anticoagulation therapy in elderly patients: TAVI and closure of LAA to avoid warfarin therapy

EuroIntervention 2012;7:1361-1363. DOI: 10.4244/EIJV7I11A213

Department of Cardiology, Heart and Diabetes Center North Rhine-Westphalia, Ruhr University Bochum, Bad Oeynhausen, Germany
The prevention of stroke is a primary goal in patients with atrial fibrillation (AF) because of its high morbidity and mortality. Cardiac embolism due to AF causes up to 25% of all ischaemic strokes underlining its supplement socio-economical relevance1. The prevalence of AF increases due to the rapidly growing proportion of elderly people. Apart from heart rate control and anticoagulation, transcatheter left atrial appendage (LAA) closure is a newly accepted therapeutic option in selected patients with permanent or paroxysmal AF who have contraindications for anticoagulation therapy and a high cardioembolic risk2,3.

Valvular heart disease, especially aortic valve stenosis (AVS), is ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
The SURTAVI model: proposal for a pragmatic risk stratification for patients with severe aortic stenosis

Latest news